Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Broad-Spectrum Antiviral Strategies and Nucleoside Analogues

13 Apr 2021

Abstract excerpt

The emergence or re-emergence of viruses with epidemic and/or pandemic potential, such as Ebola, Zika, Middle East Respiratory Syndrome (MERS-CoV), Severe Acute Respiratory Syndrome Coronavirus 1 and 2 (SARS and SARS-CoV-2) viruses, or new strains of influenza represents significant human health threats due to the absence of available treatments. Vaccines represent a key answer to control these viruses. However,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mosquito-borne diseases and control
Share to SARS-CoV-2 and COVID-19 Research
Share to Viral Infections and Outbreaks Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33924302
DOI: 10.3390/v13040667

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 21 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Broad-Spectrum Antiviral Strategies and Nucleoside AnaloguesPMID 33924302Read ↗

Discovery and Development of Safe-in-Man Broad-Spectrum Antiviral AgentsSemantic proximity Read ↗

Nucleotide and nucleoside-based drugs: past, present, and futureSemantic proximity Read ↗

Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA VirusesSemantic proximity Read ↗

Targeting viral genome synthesis as broad-spectrum approach against RNA virus infectionsSemantic proximity Read ↗

Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus InfectionsSemantic proximity Read ↗

The future of antiviralsSemantic proximity Read ↗

A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antiviralsSemantic proximity Read ↗

Small Molecule Drugs Targeting Viral PolymerasesSemantic proximity Read ↗

Expanding the frontiers of existing antiviral drugs: Possible effects of HIV-1 protease inhibitors against SARS and avian influenzaSemantic proximity Read ↗

Recent advances in small-molecular therapeutics for COVID-19Semantic proximity Read ↗

Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronavirusesSemantic proximity Read ↗

New pharmacological strategies to fight enveloped virusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.